International medical cannabis platform company Akanda Corp. expects to take a leading position in the fast-growing German medical cannabis market, as it sees its first export shipment arrive from its Portugal-based operation and announces the first sale has been achieved. Akanda recently entered into an agreement to deliver at least 1,000 kilograms of high-grade medical cannabis flower to Germany through the Cansativa platform. The deal ranks as one of the largest supply agreements in the European medical cannabis industry. Furthermore, Cansativa is also the only company in Germany permitted to distribute domestically grown cannabis. “This is an impressive milestone for Akanda’s push into the German medical cannabis market. The successful arrival of our first shipment of flower to supply patients through the Cansativa platform is an indication of the market’s demand for premium high THC medical cannabis,” commented Akanda’s CEO Tej Virk.

Recently, Akanda has also announced an exclusive license agreement with the iconic international cannabis lifestyle brand Cookies. The multi-year agreement enables Akanda to pursue the current medical and future adult-use opportunities in Europe